Proteios Technology Analysis: $225K Raised
What is Proteios Technology?
Proteios Technology develops a patented dodecapeptide affinity tag that binds micromolarly to silica substrates for protein purification. The tag enables automated purification, cell isolation, and high-throughput screening with 5x-10x lower cost and 12x higher throughput than existing methods. The platform supports multiple applications including recombinant protein purification, cell enrichment, and biosensor development.
Location
Seattle, United States
Employees
1-10
Founded
2015
Funding Status
Seed
Product Features & Capabilities
- FPLC Protein Purification Kits
- Gravity-Based Protein Purification Kits
- Spin Protein Purification Kits
- Cell Isolation Device (version 3)
- High-throughput protein purification for metalloproteins
Use Cases
Purify recombinant proteins at 15 mg yield with >90% purity; Isolate immune cells using multiple antigen criteria; Automate cell activation and expansion for gene therapies; Perform high-throughput screening of protein interactions; Enable closed-system, antibody-free cell isolation
Other Considerations
Awarded UW Environmental Health & Safety Lab Safety Award; Received $1.7M grant from Andy Hill CARE Fund to commercialize cell therapy platform; Supports isolation of over 20 cell subtypes; Patented dodecapeptide technology with micromolar affinity for silica substrates
See something that needs updating? Suggest edits to this profile.